Therapies for neurologic erectile dysfunction

References

• Papers of special note have been highlighted as:
   Google Scholar
• of interest
   Google Scholar
• of considerable interest
   Google Scholar
• Feldman HA, Goldstein I, Hatzichristou DG et al. Impotence and its medical and psychological correlates: results of the Massachusetts male aging study. J. Urol. 151, 5461 (1994).
   Web of Science ®Google Scholar
• NIH Consensus Development Panel on Impotence. Impotence. JAMA 270, 8390 (1993).
   Google Scholar
• Nehra A, Barrett DM, Moreland RB. Pharmacotherapeutic advances in the treatment of erectile dysfunction. Mayo Clin. Proc. 74, 709722 (1999).
   Google Scholar
• Detailed review of the mechanism of action of the medications used in the treatment of erectile dysfunction.
   Google Scholar
• Sharlip. Evaluation and nonsurgical management of erectile dysfunction. Urol. Clin. North Am. 25, 647659 (1998).
   Google Scholar
• Nehra A, Moreland RB. Neurologic Erectile Dysfunction. Urol. Clin. North Am. 28, 289308 (2001).
   Web of Science ®Google Scholar
• Anderson KE, Wagner G. Physiology of penile erection. Physiol. Rev. 75, 191236 (1995).
   Web of Science ®Google Scholar
• McKenna KE. Central control of penile erection. Int. J. Impot. Res. 10\(Suppl. 1), S25S34 (1998).
   Google Scholar
• Moreland RB, Nakane M, Hsieh G et al. New perspectives in the treatment of male erectile dysfunction. Cur. Opin. CPNS Drugs 2, 283302 (2000).
   Google Scholar
• Rampin O, Bernabe J, Giuliano F. Spinal control of penile erection. World J. Urol. 15, 213 (1997).
   PubMedGoogle Scholar
• Guilano FA, Rampin O, Benoit G et al. Neural control of penile erection. Urol. Clin. North Am. 22, 747766 (1995).
   Web of Science ®Google Scholar
• Chuang AT, Steers WS. Neurophysiology of penile erection. In: Textbook of Erectile Dysfunction. Carson C, Kirby R, Goldstein I (Eds). Isis Medical Media, Oxford, UK, 5972, (1999).
   Google Scholar
• Comprehensive text covering all aspects of erectile dysfunction.
   Google Scholar
• Benvenuti F, Boncinelli L, Vignoli GC. Male Sexual impotence in diabetes: vasculogenic versus neurogenic factors. Neurourol. Urodyn. 12, 145151 (1993).
   Google Scholar
• Hakim LS, Goldstein I. Diabetic sexual dysfunction. Endocrinol. Metab. Clin. North Am. 25, 379400 (1996).
   Web of Science ®Google Scholar
• Romeo JH, Seftel AD, Madhun ZT et al. Sexual function in men with diabetes type 2. Association with glycemic control. J. Urol. 163, 788791 (2000).
   Google Scholar
• Simopoulous D, Gibbons S, Malysz J et al. Corporeal structural and vascular micro architecture with X-ray micro computerized tomography in normal and diabetic rabbits: histopathological correlation. J. Urol. 165(5), 17761782 (2001).
   Web of Science ®Google Scholar
• Lilius HG, Valtonen EJ, Wikstrom J. Sexual problems in patients suffering from multiple sclerosis. Scand. J. Soc. Med. 4, 4144 (1976).
   Google Scholar
• Salinas CJ, Virseda CM, Samblas GR et al. Neurobiology of erectile dysfunction in multiple sclerosis. Arch. Esp. Urol. 51, 167 170 (1998).
   Google Scholar
• Lambert D, Walters CH. Sexual dysfunction in Parkinsons disease. Clin. Neurosci. 5, 7377 (1998).
   Google Scholar
• Andersson KE, Gemalmaz H, Waldeck K et al. The effect of sildenafil on apomorphineevoked increases in intracavernous pressure in the awake rat. J. Urol. 161, 17071712 (1999).
   Web of Science ®Google Scholar
• OSullivan JD, Hughes AJ. Apomorphineinduced penile erections in Parkinsons disease. Mov. Disord. 13, 536539 (1998).
   Web of Science ®Google Scholar
• Palmer JS, Kaplan WE, Firlit CF. Erectile dysfunction in spina bifida is treatable. Lancet 345(9173), 125126 (1999).
   Google Scholar
• Herzog AG, Siebel MM, Schomer DL et al. Reproductive endocrine disorders in men with partial seizures of temporal lobe origin. Arch. Neurol. 43, 347350 (1986).
   Google Scholar
• Herzog AG. Seizure control with clomiphene therapy: a case report. Arch. Neurol. 45, 209210 (1988).
   Google Scholar
• Lue, TF, Takamura T, Schmidt RA et al. Potential preservation of potency after radical prostatectomy. Urology 22, 165167 (1983).
   Web of Science ®Google Scholar
• Nehra A, Goldstein I. Sildenafil citrate after radical retropubic prostatectomy. Con. Urology 54, 587589 (1999).
   Google Scholar
• Walsh PC, Lepor H, Eggeston JC. Radical prostatectomy with preservation of sexual function: anatomical and pathological considerations. Prostate 4, 473485 (1983).
   Web of Science ®Google Scholar
• From a body of pioneering anatomic work from Johns Hopkins that has changed the way prostatectomy is performed today.
   Google Scholar
• Walsh PC, Marschke P, Ricker D et al. Patient-reported urinary continence and sexual function after anatomic radical prostatectomy. Urology 55, 5861 (2000).
   Web of Science ®Google Scholar
• Walsh PC, Marsche P, Catalona WJ et al. Efficacy of first-generation Cavermap to verify location and function of cavernous nerves during radical prostatectomy: a multi-institutional evaluation by experienced surgeons. Urology 57(3), 491 494 (2001).
   Web of Science ®Google Scholar
• Choy DS. Early relief of erectile dysfunction after laser decompression of herniated lumbar disk. J. Clin. Laser Med. Surg. 17, 2527 (1999).
   Google Scholar
• Maury M, Francois N, Skoda A. About the neurological sequela of herniated intravertebral disc. Paraplegia 11, 221227 (1973).
   Google Scholar
• Shah PR. Spinal cord injury. In: Textbook of Erectile Dysfunction. Carson C, Kirby R, Goldstein I (Eds). Isis Medical Media, Oxford, UK, 563568 (1999).
   Google Scholar
• Rosen RC, Riley A, Wagner G et al. The international index of erectile function (IIEF): a multidimensional scale for assessment of erectile dysfunction. Urology 49(6), 822830 (1997).
   Web of Science ®Google Scholar
• Numerous quality of life questionnaires exist for erectile dysfunction; this is the most widely used.
   Google Scholar
• Murialdo G, Galimberti CA, Fozi S et al. Sex hormones and pituitary function in male epileptics with altered or normal sexuality. Epilepsia 36, 360365 (1995).
   Web of Science ®Google Scholar
• Rolston R, Mathews M, Taylor PM et al. Hormone profile in lepromatous leprosy: A preliminary study. Int. J. Lepr. Other Mycobact. Dis. 49, 3136 (1981).
   Google Scholar
• Beck RO, Fowler CJ. Neurophysiologic testing in erectile dysfunction. In: Textbook of Erectile Dysfunction. Carson C, Kirby R, Goldstein I (Eds). Isis Medical Media, Oxford, UK, 257266 (1999).
   Google Scholar
• Broderick GA. Evidence based assessment of erectile dysfunction. Int. J. Impot. Res. 10\(Suppl. 2), S64S73 (1998).
   Google Scholar
• Rosen R, Padma-Nathan H, Goldstein I. Process of care model for the management of erectile dysfunction in a primary care setting. In: Textbook of Erectile Dysfunction. Carson C, Kirby R, Goldstein I (Eds). Isis Medical Media, Oxford, UK, 497506 (1999).
   Google Scholar
• Burnett AL. Nitric oxide in the penis: physiology and pathology. J. Urol. 157, 320324 (1997).
   Web of Science ®Google Scholar
• Moreland RB, Goldstein I, Kim NN et al. Sildenafil citrate, a selective phosphodiesterase type 5 inhibitor. Trends Endocrinol. Metab. 10, 97104 (1999).
   Google Scholar
• Goldstein I, Lue TF, Padma-Nathan H et al. Oral sildenafil in the treatment of erectile dysfunction: Sildenafil Study Group. N. Engl. J. Med. 338, 13971404 (1998).
   Web of Science ®Google Scholar
• Sato Y, Melman A, Christ GJ. Central effects of sildenafil on intracavernous pressure (ICP) following electrical stimulation of the MPOA (abstract 867). J. Urol. 163\(Suppl. 4), 196 (2000).
   Google Scholar
• Rendell MS, Rajfer J, Wicker PA et al. Sildenafil for the treatment of erectile dysfunction in men with diabetes: a randomized controlled trial. Sildenafil Diabetes Study Group. JAMA 281, 421c 426 (1999).
   Google Scholar
• Best study to date on the use of sildenafil in diabetics.
   Google Scholar
• Boulton AJ, Selam JL, Ziegler D. Sildenafil citrate for the treatment of erectile dysfunction in men with Type II diabetes mellitus. Diabetologia 44(10), 12961301 (2001).
   Web of Science ®Google Scholar
• Kalinichenko S, Kozlov GI, Melnichenko GA et al. Sildenafil citrate (Viagra) treatment in patients with diabetes mellitus. Ter. Arkh. 71, 7880 (1999).
   Google Scholar
• Hussain IF, Brady CM, Swinn MJ et al. Treatment of erectile dysfunction with sildenafil citrate (Viagra) in parkinsonism due to Parkinsons disease or multiple systems atrophy with observations on orthostatic hypotension. J. Neur. Neurosurg. Psych. 71(3), 371 374 (2001).
   Google Scholar
• Fowler C, Miller J, Sharief M. Viagra (sildenafil citrate) for the treatment of erectile dysfunction in men with multiple sclerosis. Ann. Neurol. 46, 497 (1999).
   Google Scholar
• Palmer JS, Kaplan WE, Firlit CF. Erectile dysfunction in spina bifida is treatable. Lancet 354(9173), 12126 (1999).
   Web of Science ®Google Scholar
• Giuliano F, Hultling C, El Masry WS et al. Randomized trial of sildenafil for the treatment of erectile dysfunction in spinal cord injury. Sildenafil Study Group. Ann. Neurol. 46, 1521 (1999).
   Google Scholar
• Maytom MC, Derry FA, Dinsmore WW et al. A two-part pilot study of sildenafil (VIAGRA) in men with erectile dysfunction caused by spinal cord injury. Spinal Cord. 37, 110116, (1999).
   Web of Science ®Google Scholar
• Hutling C. Guiliano F. Quirk F et al. Quality of life in patients with spinal cord injury receiving Viagra (sildenafil citrate) for the treatment of erectile dysfunction. Spinal Cord. 38(6), 363370 (2000).
   Google Scholar
• A multicenter, randomized trial reviewing sildenafil success in spinal cord injured patients.
   Google Scholar
• Zippe CD, Jhaveri FM, Klein EA et al. Role of Viagra after radical prostatectomy. Urology 55, 241245 (2000).
   Web of Science ®Google Scholar
• Padwa-Nathan H, Giuliano F. Oral therapy for erectile dysfunction. Urol. Clin. North Am. 28(2), 321333 (2001).
   Google Scholar
• Oakley N, Allen P, Moore KTH. Vacuum devices for penile erection. In: Textbook of Erectile Dysfunction. Carson C, Kirby R, Goldstein I (Eds). Isis Medical Media, Oxford, UK, 371381 (1999).
   Google Scholar
• Aloni R, Heller L, Keren O et al. Noninvasive treatment for erectile dysfunction in the neurologically disabled population. J. Sex Marital Ther. 18, 243 249 (1992).
   Web of Science ®Google Scholar
• Denil J, Ohl DA, Smythe C. Vacuum erection device in spinal cord injured men: patient and partner satisfaction. Arch. Phys. Med. Rehabil. 77, 750753 (1996).
   Google Scholar
• Ganem JP, Lucey DT, Janosko EO et al. Unusual complications of the vacuum erection device. Urology 51, 627631 (1998).
   Web of Science ®Google Scholar
• Chen J, Mabjeesh N, Greenstein A. Sildenafil versus the vacuum erection device: patient preference. J. Urol. 166(5), 17791781 (2001).
   Google Scholar
• Spahn M, Manning M, Juenemann KP. Intracavernosal therapy. In: Textbook of Erectile Dysfunction. Carson C, Kirby R, Goldstein I (Eds). Isis Medical Media, Oxford, UK. 345352, (1999).
   Google Scholar
• Linet OI, Orgrinc FG, and the Alprostadil Study Group. Efficacy and safety of intracavernosal alprostadil in men with erectile dysfunction. N. Engl. J. Med. 334, 873877, (1996).
   Google Scholar
• Shabsigh R, Padma-Nathan, Gittleman M, et al. Intracavernous alprostadil alfadex (EDEX/ VIRIDAL) is effective and safe in patients with erectile dysfunction after failing sildenafil (Viagra). Urology 55, 477480 (2000).
   Web of Science ®Google Scholar
• Padma-Nathan H, Hellstrom WJ, Kaiser FE et al. Treatment of men with erectile dysfunction with transurethral alprostadil: medicated urethral system for erection (MUSE) Study Group. N. Engl. J. Med. 336, 17 (1997).
   Web of Science ®Google Scholar
• Bodner DR, Haas CA, Krueger B et al. Intraurethral alprostadil for treatment of erectile dysfunction in patients with spinal cord injury. Urology 53, 199202 (1999).
   Web of Science ®Google Scholar
• Hirsch IH, Smith RL, Chancellor MB et al. Use of intracavernous injection of prostaglandin E1 for neuropathic erectile dysfunction. Paraplegia 32, 661664 (1994).
   Google Scholar
• Vidal J, Curcoll L, Roig T et al. Intracavernous pharmacotherapy for management of erectile dysfunction in multiple sclerosis patients. Rev. Neurol. 23, 269271 (1995).
   Google Scholar
• Montorsi F, Guazzoni G, Strambi LF et al. Recovery of spontaneous erectile function after nerve-sparing radical retropubic prostatectomy with and without early intracavernous injections of alprostadil: results of a prospective, randomized trial. J. Urol. 158, 14081410 (1997).
   Web of Science ®Google Scholar
• Dinsmore WW, Gingell C, Hackett G et al. Treating men with predominantly nonpsychogenic erectile dysfunction with intracavernosal vasoactive intestinal polypeptide and phentolamine mesylate in a novel auto-injector system: a multicenter double-blind placebo-controlled study. Br. J. Urol. Int. 83, 274279 (1999).
   Google Scholar
• Nehra A, Hakim LS, Barrett DM et al. Effectiveness of combination therapy of MUSE and Viagra in the salvage of erectile dysfunction patients desiring noninvasive therapy: 18-month follow-up. J. Urol. 163\(Suppl. 4), 198 (2000).
   Google Scholar
• Chao R, Clowers DE. Experience with intracavernosal trimixture for the management of neurogenic erectile dysfunction. Arch. Phys. Med. Rehabil. 75, 276278 (1994).
   Web of Science ®Google Scholar
• Carson CC. Complications of penile prosthesis and complex implantations. In: Textbook of Erectile Dysfunction. Carson C, Kirby R, Goldstein I (Eds). Isis Medical Media, Oxford, UK, 435450 (1999).
   Google Scholar
• Carson CC, Mulcahy JJ, Govier FE. Efficacy, safety and patient satisfaction outcomes of the AMS 700CX inflatable penile prosthesis: results of a long-term multicenter study. AMS 700CX Study Group. J. Urol. 164(2), 376380 (2000).
   Google Scholar
• Large multi-institutional review of this commonly used inflatable penile prosthesis.
   Google Scholar
• Shabsigh R. Socioeconomic considerations in erectile dysfunction treatment. Urol. Clin. North Am. 28(2), 417422 (2001).
   Google Scholar
• Muller HW, Stoll G. Nerve injury and regeneration: basic insights and therapeutic inventions. Curr. Opin. Neurol. 11, 557 562 (1998).
   Web of Science ®Google Scholar
• Carrier S, Zvara P, Nunes L et al. Regeneration of nitric oxide synthase-containing nerves after cavernous nerve neurotomy in the rat. J. Urol. 153, 17221727 (1995).
   Web of Science ®Google Scholar
• Jung GW, Kwak JY, Yoon S, et al. IGF-I and TGF-1 have a key role on regeneration of nitric oxide synthase (NOS)-containing nerves after cavernous neurotomy in rats. Int. J. Impot. Res. 11, 247259 (1999).
   Google Scholar
• Jung GW, Spencer EM, Lue TF. Growth hormone enhances regeneration of nitric oxide synthase-containing penile nerves after cavernous nerve neurotomy in rats. J. Urol. 160, 18991904 (1998).
   Google Scholar
• An animal model for cavernosal nerve regeneration.
   Google Scholar
• Apfel SC. Neurotrophic factors in the therapy of diabetic neuropathy. Am. J. Med. 107(2B), S34S42 (1999).
   Google Scholar
• Zochodne DW, Cheng C. Neurotrophins and other growth factors in the regenerative milieu of proximal nerve stump tips. J. Anat. 196(2), 279283 (2000).
   Google Scholar
• Melman A, Christ G. The effects of age and disease on gap junctions and ion channels and their potential value to the treatment of erectile dysfunction. Urol. Clin. North Am. 28(2), 217231 (2001).
   Google Scholar
• Kim ED, Nath R, Kadmon D et al. Bilateral nerve graft during radical retropubic prostatectomy: 1-year follow-up. J. Urol. 165(6), 19501956 (2001).
   Google Scholar
• One of the first studies on this unproven technique which holds great interest in the urologic community.
   Google Scholar